23andMe Wins A Second Life: New Business Plan Scores $115 Million From Investors

This morning, 23andMe, the Silicon Valley maker of over-the-counter genetic tests, is announcing that it is raising $115 million from investors including Fidelity Management & Research Company, Casdin Capital and WuXi Healthcare Ventures, bringing the total raised by the company to $241 million. Forbes understands the investment values 23andMe at $1.1 billion.
Read more: http://ift.tt/1PiFJAM